Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry

Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.

1992

Género: Conflict of interests

Ver ficha completa

Añadir a mi colección

Formato